Research output per year
Research output per year
Fingerprint
Dive into the research topics where Rana K Zabad is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial
Cree, B. A. C., Cutter, G., Wolinsky, J. S., Freedman, M. S., Comi, G., Giovannoni, G., Hartung, H. P., Arnold, D., Kuhle, J., Block, V., Munschauer, F. E., Sedel, F., Lublin, F. D., Reingold, S., Duquette, P., Derfuss, T., Fazekas, F., Sormani, M. P., Lisak, R. P., Graves, J. & 94 others, , Dec 2020, In: The Lancet Neurology. 19, 12, p. 988-997 10 p.Research output: Contribution to journal › Article › peer-review
10 Scopus citations -
Sex effects across the lifespan in women with multiple sclerosis
Krysko, K. M., Graves, J. S., Dobson, R., Altintas, A., Amato, M. P., Bernard, J., Bonavita, S., Bove, R., Cavalla, P., Clerico, M., Corona, T., Doshi, A., Fragoso, Y., Jacobs, D., Jokubaitis, V., Landi, D., Llamosa, G., Longbrake, E. E., Maillart, E., Marta, M. & 10 others, , 2020, In: Therapeutic Advances in Neurological Disorders. 13Research output: Contribution to journal › Review article › peer-review
Open Access8 Scopus citations -
Multiple Sclerosis at Home Access (MAHA): An initiative to improve care in the community
Healey, K., Zabad, R., Young, L., Lindner, A., Lenz, N., Stewart, R. & Charlton, M., May 1 2019, In: International Journal of MS Care. 21, 3, p. 101-112 12 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Overlapping demyelinating syndrome and anti-N-methyl-D-aspartate receptor encephalitis with seizures
Taraschenko, O. & Zabad, R., 2019, In: Epilepsy and Behavior Reports. 12, 100338.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
ASCEND investigators, May 2018, In: The Lancet Neurology. 17, 5, p. 405-415 11 p.Research output: Contribution to journal › Article › peer-review
93 Scopus citations